File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Narrow-Band Imaging for Detection of Neoplasia at Colonoscopy: A Meta-analysis of Data From Individual Patients in Randomized Controlled Trials

TitleNarrow-Band Imaging for Detection of Neoplasia at Colonoscopy: A Meta-analysis of Data From Individual Patients in Randomized Controlled Trials
Authors
KeywordsAdenoma Detection Rate
Colorectal Cancer
Serrated Polyps
Tumor
Issue Date2019
PublisherWB Saunders Co. The Journal's web site is located at http://www.elsevier.com/locate/gastro
Citation
Gastroenterology, 2019, v. 157 n. 2, p. 462-471 How to Cite?
AbstractBackground & Aims: Adenoma detection rate (ADR) is an important quality assurance measure for colonoscopy. Some studies suggest that narrow-band imaging (NBI) may be more effective at detecting adenomas than white-light endoscopy (WLE) when bowel preparation is optimal. We conducted a meta-analysis of data from individual patients in randomized controlled trials that compared the efficacy of NBI to WLE in detection of adenomas. Methods: We searched MEDLINE, EMBASE, and Cochrane Library databases through April 2017 for randomized controlled trials that assessed detection of colon polyps by high-definition WLE vs NBI and from which data on individual patients were available. The primary outcome measure was ADR adjusted for bowel preparation quality. Multilevel regression models were used with patients nested within trials, and trial included as a random effect. Results: We collected data from 11 trials, comprising 4491 patients and 6636 polyps detected. Adenomas were detected in 952 of 2251 (42.3%) participants examined by WLE vs 1011 of 2239 (45.2%) participants examined by NBI (unadjusted odds ratio [OR] for detection of adenoma by WLE vs NBI, 1.14; 95% CI, 1.01–1.29; P = .04). NBI outperformed WLE only when bowel preparation was best: adequate preparation OR, 1.07 (95% CI, 0.92–1.24; P = .38) vs best preparation OR, 1.30 (95% CI, 1.04–1.62; P = .02). Second-generation bright NBI had a better ADR than WLE (second-generation NBI OR, 1.28; 95% CI, 1.05–1.56; P = .02), whereas first-generation NBI did not. NBI detected more non-adenomatous polyps than WLE (OR, 1.24; 95% CI, 1.06–1.44; P = .008) and flat polyps than WLE (OR, 1.24; 95% CI, 1.02–1.51; P = .03). Conclusions: In a meta-analysis of data from individual patients in randomized controlled trials, we found NBI to have a higher ADR than WLE, and that this effect is greater when bowel preparation is optimal.
Persistent Identifierhttp://hdl.handle.net/10722/273426
ISSN
2021 Impact Factor: 33.883
2020 SCImago Journal Rankings: 7.828
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorAtkinson, NSS-
dc.contributor.authorKet, S-
dc.contributor.authorBassett, P-
dc.contributor.authorAponte, D-
dc.contributor.authorDe Aguiar, SD-
dc.contributor.authorGupta, N-
dc.contributor.authorHorimatsu, T-
dc.contributor.authorIkematsu, H-
dc.contributor.authorInoue, T-
dc.contributor.authorKaltenbach, T-
dc.contributor.authorLeung, WK-
dc.contributor.authorMatsuda, T-
dc.contributor.authorPaggi, S-
dc.contributor.authorRadaelli, F-
dc.contributor.authorRastogi, A-
dc.contributor.authorRex, DK-
dc.contributor.authorSabbagh, LC-
dc.contributor.authorSaito, Y-
dc.contributor.authorSano, Y-
dc.contributor.authorSoracco, GM-
dc.contributor.authorSaunders, BP-
dc.contributor.authorSenore, C-
dc.contributor.authorSoetikno, R-
dc.contributor.authorVemulapalli, KC-
dc.contributor.authorJairath, V-
dc.contributor.authorEast, JE-
dc.date.accessioned2019-08-06T09:28:43Z-
dc.date.available2019-08-06T09:28:43Z-
dc.date.issued2019-
dc.identifier.citationGastroenterology, 2019, v. 157 n. 2, p. 462-471-
dc.identifier.issn0016-5085-
dc.identifier.urihttp://hdl.handle.net/10722/273426-
dc.description.abstractBackground & Aims: Adenoma detection rate (ADR) is an important quality assurance measure for colonoscopy. Some studies suggest that narrow-band imaging (NBI) may be more effective at detecting adenomas than white-light endoscopy (WLE) when bowel preparation is optimal. We conducted a meta-analysis of data from individual patients in randomized controlled trials that compared the efficacy of NBI to WLE in detection of adenomas. Methods: We searched MEDLINE, EMBASE, and Cochrane Library databases through April 2017 for randomized controlled trials that assessed detection of colon polyps by high-definition WLE vs NBI and from which data on individual patients were available. The primary outcome measure was ADR adjusted for bowel preparation quality. Multilevel regression models were used with patients nested within trials, and trial included as a random effect. Results: We collected data from 11 trials, comprising 4491 patients and 6636 polyps detected. Adenomas were detected in 952 of 2251 (42.3%) participants examined by WLE vs 1011 of 2239 (45.2%) participants examined by NBI (unadjusted odds ratio [OR] for detection of adenoma by WLE vs NBI, 1.14; 95% CI, 1.01–1.29; P = .04). NBI outperformed WLE only when bowel preparation was best: adequate preparation OR, 1.07 (95% CI, 0.92–1.24; P = .38) vs best preparation OR, 1.30 (95% CI, 1.04–1.62; P = .02). Second-generation bright NBI had a better ADR than WLE (second-generation NBI OR, 1.28; 95% CI, 1.05–1.56; P = .02), whereas first-generation NBI did not. NBI detected more non-adenomatous polyps than WLE (OR, 1.24; 95% CI, 1.06–1.44; P = .008) and flat polyps than WLE (OR, 1.24; 95% CI, 1.02–1.51; P = .03). Conclusions: In a meta-analysis of data from individual patients in randomized controlled trials, we found NBI to have a higher ADR than WLE, and that this effect is greater when bowel preparation is optimal.-
dc.languageeng-
dc.publisherWB Saunders Co. The Journal's web site is located at http://www.elsevier.com/locate/gastro-
dc.relation.ispartofGastroenterology-
dc.subjectAdenoma Detection Rate-
dc.subjectColorectal Cancer-
dc.subjectSerrated Polyps-
dc.subjectTumor-
dc.titleNarrow-Band Imaging for Detection of Neoplasia at Colonoscopy: A Meta-analysis of Data From Individual Patients in Randomized Controlled Trials-
dc.typeArticle-
dc.identifier.emailLeung, WK: waikleung@hku.hk-
dc.identifier.authorityLeung, WK=rp01479-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1053/j.gastro.2019.04.014-
dc.identifier.pmid30998991-
dc.identifier.scopuseid_2-s2.0-85069568527-
dc.identifier.hkuros300753-
dc.identifier.volume157-
dc.identifier.issue2-
dc.identifier.spage462-
dc.identifier.epage471-
dc.identifier.isiWOS:000476476800034-
dc.publisher.placeUnited States-
dc.identifier.issnl0016-5085-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats